Indication

Hyper-IgD periodic fever syndrome

Hyper-IgD periodic fever syndrome is a rare, autosomal recessive autoinflammatory disorder representing the milder phenotypic presentation of mevalonate kinase deficiency. Read more about Hyper-IgD periodic fever syndrome

3 drugs 2 manufacturers

Advertisement

Drugs that treat it

Common Hyper-IgD periodic fever syndrome therapies.

Showing 1–3 of 3 drugs

ILARIS (canakinumab/PF)

ANTI-INFLAMMATORY - INTERLEUKIN 1 RECEPTOR ANTAGONIST·ACUTE GOUTY ARTHRITIS·+7
Novartis Pharmaceuticals

ILARIS (canakinumab/PF)

ANTI-INFLAMMATORY - INTERLEUKIN 1 RECEPTOR ANTAGONIST·ACUTE GOUTY ARTHRITIS·+7
Novartis Pharmaceuticals
Filter & compare in the drug finder →Opens the drug finder with Hyper-IgD periodic fever syndrome preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Hyper-IgD periodic fever syndrome.

Hyper-IgD periodic fever syndrome is a rare, autosomal recessive autoinflammatory disorder representing the milder phenotypic presentation of mevalonate kinase deficiency.

Primarily manifesting during infancy or early childhood, the condition affects systemic innate immunity and is most frequently identified in individuals of Northern European descent.

It is pathophysiologically driven by loss-of-function variants in the *MVK* gene, which disrupt the mevalonate-cholesterol biosynthesis pathway and precipitate excessive, unprovoked interleukin-1–driven systemic inflammation.

Clinically, affected patients experience recurrent febrile episodes—frequently triggered by vaccinations, infection, or physiologic stress—lasting three to seven days and accompanied by painful cervical lymphadenopathy, abdominal pain, aphthous stomatitis, arthralgia, and cutaneous eruptions, alongside persistently elevated serum immunoglobulin D levels in most individuals.

Personalize your experience

Follow Hyper-IgD periodic fever syndrome and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it